- Home
- ARW vs HALO Comparison
ARW vs HALO Comparison
Compare ARW & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARW
- HALO
- Stock Information
- Founded
- ARW 1935
- HALO 1998
- Country
- ARW United States
- HALO United States
- Employees
- ARW N/A
- HALO N/A
- Industry
- ARW Electronic Components
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ARW Technology
- HALO Health Care
- Exchange
- ARW Nasdaq
- HALO Nasdaq
- Market Cap
- ARW 6.7B
- HALO 7.6B
- IPO Year
- ARW N/A
- HALO N/A
- Fundamental
- Price
- ARW $111.60
- HALO $66.14
- Analyst Decision
- ARW Hold
- HALO Buy
- Analyst Count
- ARW 4
- HALO 10
- Target Price
- ARW $114.75
- HALO $73.20
- AVG Volume (30 Days)
- ARW 705.0K
- HALO 1.7M
- Earning Date
- ARW 10-30-2025
- HALO 11-03-2025
- Dividend Yield
- ARW N/A
- HALO N/A
- EPS Growth
- ARW 1.13
- HALO 68.93
- EPS
- ARW 9.07
- HALO 4.37
- Revenue
- ARW $29,389,382,000.00
- HALO $1,178,672,000.00
- Revenue This Year
- ARW $10.15
- HALO $32.47
- Revenue Next Year
- ARW $6.03
- HALO $24.31
- P/E Ratio
- ARW $12.50
- HALO $15.16
- Revenue Growth
- ARW 3.16
- HALO 34.97
- 52 Week Low
- ARW $86.50
- HALO $42.01
- 52 Week High
- ARW $134.74
- HALO $79.50
- Technical
- Relative Strength Index (RSI)
- ARW 33.21
- HALO 43.94
- Support Level
- ARW $106.58
- HALO $63.90
- Resistance Level
- ARW $123.02
- HALO $66.97
- Average True Range (ATR)
- ARW 3.62
- HALO 1.62
- MACD
- ARW -0.79
- HALO 0.07
- Stochastic Oscillator
- ARW 25.06
- HALO 60.12
About ARW Arrow Electronics Inc.
Arrow Electronics Inc. is a provider of products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions. It has one of the world's broadest portfolios of product offerings available from electronic components and enterprise computing solutions suppliers, coupled with a range of services, solutions, and software, the company helps industrial and commercial customers introduce products, reduce their time to market, and enhance their overall competitiveness. The company has two business segments, the components business and the enterprise computing solutions.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.